Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adagio Medical Holdings, Inc - Common Stock (NQ:ADGM)

0.1061 +0.0061 (+6.10%)
Delayed Quote Updated: 3:58 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Adagio Medical Holdings, Inc - Common Stock

< Previous 1 2 Next >
News headline image
Adagio Medical Announces Strategic Review Process to Maximize Shareholder Value
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center Phoenix
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Reports Second Quarter 2026 Results
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Kartoon Studios (NYSE: TOON) Among ADGM, QNME, AMIX Strengthens Consumer Strategy with Former Activision Blizzard Licensing Executive
Via AB Newswire
News headline image
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia
From Adagio Medical Holdings, Inc
Via Business Wire
News headline image
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical’s ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical to Participate in the 25th Annual Needham Virtual Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical to Participate in the 38th Annual Roth Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia
From Adagio Medical Holdings, Inc
Via Business Wire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors
From Adagio Medical Holdings, Inc
Via Business Wire
News headline image
Adagio Medical Reports Third Quarter 2025 Results
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities
From Adagio Medical Holdings, Inc.
Via Business Wire
News headline image
Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium
From Adagio Medical Holdings, Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.